Future studies should aim to elucidate the precise molecular mechanisms underlying the PDPN-mediated inflammatory response in T2DM astrocytes and explore the therapeutic potential of targeting PDPN in the treatment of diabetic encephalopathy. The gene discussed is PDPN; the disease is diabetic encephalopathy.